Nifty

:

23306.45

Sensex

:

75273.45

394.05 (1.72%)
1205.00 (1.63%)

Login

Nifty
Sensex

:
:

23306.45
75273.45

394.05 (1.72%)
1205.00 (1.63%)

Procter & Gamble Health Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

68/99

BSE: 500126 | NSE: PGHL

Watchlist

NSE BSE

4936.70

25-Mar-2026

Open
High
Low
Previous Close

4805.1
4976.3
4805.1
4843.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

14879
72960427.6
6739
4725

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,199.10
27.94
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,912.93
2.53%
11.76

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

39.99
37.21
36.65

P:BV (Average)

8 Years
5 Years
3 Years

12.14
12.71
13.12

EV:EBITDA (Average)

8 Years
5 Years
3 Years

25.68
25.14
23.52

Earnings Forecasts:

(Updated: 21-03-2026)

Description 2024 2025 2026 2027
Adj EPS 188.3 195.15 222.35
P/E Ratio 26.22 25.30 22.20
Revenue 934.2 1388.05 1547.1
EBITDA 318.4 433.55 493.35
Net Income 234.4 313.8 359.05
ROA
P/B Ratio 9.21 7.43
ROE 77.5 45.5 42.15
FCFF 182.1 332.65 346.35
FCFF Yield 2.28626 4.17642 4.34842
Net Debt
BVPS 536 664.2

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 373.86 309.77 20.69% 324.92 313.41 3.67% 338.74 283.88 19.33% 310.99 252.48 23.17%
Expenses 263.40 186.34 41.35% 204.65 199.37 2.65% 248.40 235.63 5.42% 230.07 185.04 24.34%
EBITDA 110.46 123.43 -10.51% 120.27 114.04 5.46% 90.34 48.25 87.23% 80.92 67.44 19.99%
EBIDTM 29.55% 39.85% 37.02% 36.39% 26.67% 17.00% 26.02% 26.71%
Other Income 4.36 3.96 10.10% 4.95 3.28 50.91% 4.03 2.13 89.20% 3.11 2.27 37.00%
Interest 0.10 0.15 -33.33% 0.12 0.15 -20.00% 0.12 0.20 -40.00% 0.13 0.15 -13.33%
Depreciation 5.90 5.55 6.31% 6.08 5.77 5.37% 5.44 7.16 -24.02% 5.37 6.84 -21.49%
PBT 108.82 121.69 -10.58% 119.02 111.40 6.84% 88.81 22.83 289.01% 78.53 62.72 25.21%
Tax 31.23 30.79 1.43% 30.48 29.07 4.85% 22.63 6.05 274.05% 17.35 16.16 7.36%
PAT 77.59 90.90 -14.64% 88.54 82.33 7.54% 66.18 16.78 294.40% 61.18 46.56 31.40%
PATM 20.75% 29.34% 27.25% 26.27% 19.54% 5.91% 19.67% 18.44%
EPS 46.74 54.76 -14.65% 53.34 49.60 7.54% 39.87 10.11 294.36% 36.86 28.05 31.41%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Jun 24 Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15
Net Sales 1,348.51 934.17 1,151.26 1,229.62 1,114.41 1,008.73 1,355.86 848.99 698.13 992.56 939.50 Net Sales Growth 16.30% -18.86% -6.37% 10.34% 10.48% -25.60% 59.70% 21.61% -29.66% 5.65% Cost Of Goods Sold 370.93 262.50 330.56 361.84 339.80 312.12 431.44 269.36 236.94 411.54 437.19 Gross Profit 977.58 671.67 820.70 867.78 774.61 696.61 924.42 579.63 461.19 581.02 502.31 GP Margin 72.49% 71.90% 71.29% 70.57% 69.51% 69.06% 68.18% 68.27% 66.06% 58.54% 53.47% Total Expenditure 946.52 615.78 845.26 904.94 846.73 762.71 1,041.52 704.85 627.50 876.99 856.06 Power & Fuel Cost - 5.82 8.50 12.88 14.70 12.97 19.09 12.23 11.68 14.96 15.14 % Of Sales - 0.62% 0.74% 1.05% 1.32% 1.29% 1.41% 1.44% 1.67% 1.51% 1.61% Employee Cost - 142.06 215.16 206.17 167.56 153.66 182.93 131.27 109.88 154.23 123.17 % Of Sales - 15.21% 18.69% 16.77% 15.04% 15.23% 13.49% 15.46% 15.74% 15.54% 13.11% Manufacturing Exp. - 81.00 113.33 126.07 132.01 125.61 121.02 72.37 69.14 58.36 70.81 % Of Sales - 8.67% 9.84% 10.25% 11.85% 12.45% 8.93% 8.52% 9.90% 5.88% 7.54% General & Admin Exp. - 68.56 99.67 87.16 60.88 51.79 153.86 94.39 82.02 141.55 116.30 % Of Sales - 7.34% 8.66% 7.09% 5.46% 5.13% 11.35% 11.12% 11.75% 14.26% 12.38% Selling & Distn. Exp. - 42.33 52.65 74.49 109.45 87.41 118.96 115.66 90.72 81.36 84.61 % Of Sales - 4.53% 4.57% 6.06% 9.82% 8.67% 8.77% 13.62% 12.99% 8.20% 9.01% Miscellaneous Exp. - 13.51 25.39 36.33 22.33 19.15 14.22 9.57 27.12 14.99 84.61 % Of Sales - 1.45% 2.21% 2.95% 2.00% 1.90% 1.05% 1.13% 3.88% 1.51% 0.94% EBITDA 401.99 318.39 306.00 324.68 267.68 246.02 314.34 144.14 70.63 115.57 83.44 EBITDA Margin 29.81% 34.08% 26.58% 26.40% 24.02% 24.39% 23.18% 16.98% 10.12% 11.64% 8.88% Other Income 16.45 10.35 15.63 18.39 13.19 18.10 69.96 28.40 30.41 24.41 23.31 Interest 0.47 0.43 0.72 0.77 0.42 0.80 0.00 0.00 0.00 0.00 0.00 Depreciation 22.79 16.69 27.40 28.10 27.08 30.04 29.45 21.12 19.12 24.81 23.42 PBT 395.18 311.62 293.51 314.20 253.37 233.28 354.85 151.42 81.92 115.17 83.33 Tax 101.69 77.21 72.34 84.73 60.85 56.48 100.77 56.24 37.88 36.04 29.77 Tax Rate 25.73% 24.78% 26.47% 26.97% 24.02% 24.21% 28.40% 35.60% 38.29% 31.29% 35.73% PAT 293.49 234.41 200.98 229.47 192.52 176.80 254.08 101.74 61.04 79.13 53.56 PAT before Minority Interest 293.49 234.41 200.98 229.47 192.52 176.80 254.08 101.74 61.04 79.13 53.56 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 21.76% 25.09% 17.46% 18.66% 17.28% 17.53% 18.74% 11.98% 8.74% 7.97% 5.70% PAT Growth 24.06% 16.63% -12.42% 19.19% 8.89% -30.42% 149.73% 66.68% -22.86% 47.74% EPS 176.80 141.21 121.07 138.23 115.98 106.51 153.06 61.29 36.77 47.67 32.27

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Jun 24 Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15
Shareholder's Funds 536.96 538.24 750.89 616.49 703.71 906.34 1,540.11 733.26 663.82 591.55 Share Capital 16.60 16.60 16.60 16.60 16.60 16.60 16.60 16.60 16.60 16.60 Total Reserves 515.47 513.11 726.45 592.61 683.24 887.80 1,523.51 716.66 647.22 574.95 Non-Current Liabilities 6.87 3.52 803.00 713.63 723.42 667.16 494.83 430.50 398.93 395.03 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 36.12 29.64 818.79 732.68 739.90 681.10 510.01 455.27 413.06 395.71 Current Liabilities 215.31 218.91 679.08 607.73 550.68 538.62 547.69 352.19 300.50 538.89 Trade Payables 171.60 167.00 237.04 172.08 178.91 123.96 91.42 83.28 75.10 65.55 Other Current Liabilities 33.29 38.22 42.49 42.32 36.64 94.51 78.02 82.21 68.23 61.03 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 10.42 13.69 399.55 393.33 335.13 320.15 378.25 186.70 157.17 412.31 Total Liabilities 759.14 760.67 2,232.97 1,937.85 1,977.81 2,112.12 2,582.63 1,515.95 1,363.25 1,525.47 Net Block 111.74 126.60 141.72 109.06 100.96 97.92 99.76 115.07 110.66 131.73 Gross Block 222.08 223.32 263.07 241.11 214.90 199.57 185.60 191.51 143.96 271.28 Accumulated Depreciation 110.34 96.72 121.35 131.32 113.94 101.65 61.39 51.22 24.82 139.55 Non Current Assets 232.75 236.45 1,061.69 953.98 938.96 847.28 693.45 636.69 613.07 579.47 Capital Work in Progress 10.96 5.89 32.49 40.60 39.15 21.45 17.35 8.90 29.98 7.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 105.68 102.06 885.23 801.72 795.90 724.61 572.52 511.59 470.50 440.74 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.13 1.93 0.00 Current Assets 526.39 524.22 1,171.28 983.87 1,038.85 1,264.84 1,889.18 879.26 750.18 946.00 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 69.97 27.78 42.28 Inventories 109.37 109.11 134.94 115.21 118.37 134.11 113.35 157.74 163.94 166.86 Sundry Debtors 145.40 85.33 115.71 83.44 59.81 95.27 66.17 122.66 107.04 126.57 Cash & Bank 188.55 244.36 440.22 324.53 468.91 639.09 1,243.42 278.18 279.27 188.42 Other Current Assets 83.07 24.17 13.73 7.95 391.76 396.37 466.24 250.71 172.15 421.87 Short Term Loans & Adv. 59.95 61.25 466.68 452.74 385.40 388.61 435.63 221.21 145.19 403.46 Net Current Assets 311.08 305.31 492.20 376.14 488.17 726.22 1,341.49 527.07 449.68 407.11 Total Assets 759.14 760.67 2,232.97 1,937.85 1,977.81 2,112.12 2,582.63 1,515.95 1,363.25 1,525.47

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Jun 24 Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15
Cash From Operating Activity 168.69 228.29 236.01 169.52 247.26 235.37 -130.39 53.66 107.04 83.47 PBT 311.62 273.32 314.20 253.37 233.28 354.85 1,137.57 152.19 115.18 83.33 Adjustment 12.20 52.27 41.49 27.31 40.89 -12.16 -913.68 7.66 14.87 16.32 Changes in Working Capital -73.81 -12.12 -30.02 -47.30 41.22 -5.73 -50.26 -46.66 30.11 15.64 Cash after chg. in Working capital 250.01 313.47 325.67 233.38 315.39 336.96 173.63 113.19 160.16 115.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -81.32 -85.18 -89.66 -63.86 -68.13 -101.59 -304.02 -59.53 -53.12 -31.82 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 9.59 -6.87 -21.50 -25.54 -32.27 164.64 1,269.72 -47.63 -74.97 -67.84 Net Fixed Assets -3.83 66.35 -13.85 -27.66 -33.03 -18.07 -2.54 -26.47 104.34 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 69.97 -42.19 14.50 Others 13.42 -73.22 -7.65 2.12 0.76 182.71 1,202.29 21.03 -193.81 Cash from Financing Activity -234.74 -418.11 -98.47 -288.63 -386.63 -883.41 -30.12 -21.98 -14.98 -11.92 Net Cash Inflow / Outflow -56.46 -196.69 116.04 -144.65 -171.64 -483.40 1,109.21 -15.95 17.09 3.71 Opening Cash & Equivalents 238.73 435.42 319.40 464.05 635.69 1,119.09 9.88 26.27 9.18 5.47 Closing Cash & Equivalent 182.27 238.73 435.44 319.40 464.05 635.69 1,119.09 10.32 26.27 9.18

Financial Ratios

Standalone

Right to Left

Description Mar 25 Jun 24 Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15
Book Value (Rs.) 320.52 319.10 447.62 366.99 421.59 544.82 927.78 441.72 399.89 356.36 ROA 30.85% 13.43% 11.00% 9.83% 8.65% 10.82% 40.93% 6.52% 5.48% 3.92% ROE 44.15% 31.58% 33.94% 29.41% 22.04% 20.79% 73.79% 13.44% 12.61% 9.35% ROCE 58.05% 42.52% 46.07% 38.45% 29.08% 29.01% 80.76% 21.79% 18.35% 14.54% Fixed Asset Turnover 4.62 5.18 5.27 5.17 4.87 7.04 6.83 4.24 4.96 3.87 Receivable days 40.92 29.14 27.36 22.20 28.06 21.73 26.75 58.92 41.40 43.30 Inventory Days 38.75 35.37 34.37 36.19 45.68 33.31 38.41 82.51 58.63 64.49 Payable days 235.41 223.07 206.35 188.51 177.09 43.33 49.94 53.71 33.69 25.86 Cash Conversion Cycle -155.74 -158.56 -144.61 -130.12 -103.36 11.71 15.22 87.72 66.33 81.93 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 725.70 380.61 409.05 604.26 292.60 0.00 0.00 0.00 0.00 0.00

Top Investors:

nippon life india trustee ltd-a/c nippon india sma

icici prudential pharma healthcare and diaganostic

life insurance corporation of india

investor education and protection fund (iepf)

Annual Reports:

News Update:

Procter&Gamble Healt - Quarterly Results
7th Feb 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback